Document is current
Any future updates will be listed below
-
Authors
Cao, Zhipeng https://orcid.org/0000-0003-2624-2182
Cupertino, Renata B. https://orcid.org/0000-0002-3452-0632
Ottino-Gonzalez, Jonatan
Murphy, Alistair https://orcid.org/0000-0001-9382-2625
Pancholi, Devarshi
Juliano, Anthony
Chaarani, Bader https://orcid.org/0000-0002-3932-6273
Albaugh, Matthew
Yuan, Dekang
Schwab, Nathan
Stafford, James
Goudriaan, Anna E.
Hutchison, Kent
Li, Chiang-Shan R. https://orcid.org/0000-0002-9393-1212
Luijten, Maartje
Groefsema, Martine
Momenan, Reza
Schmaal, Lianne https://orcid.org/0000-0001-9822-048X
Sinha, Rajita https://orcid.org/0000-0003-3012-4349
van Holst, Ruth J.
Veltman, Dick J.
Wiers, Reinout W.
Porjesz, Bernice
Lett, Tristram https://orcid.org/0000-0002-0731-9626
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta
Grigis, Antoine
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère https://orcid.org/0000-0002-0452-2450
Artiges, Eric https://orcid.org/0000-0003-4461-7646
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Orfanos, Dimitri Papadopoulos https://orcid.org/0000-0002-1242-8990
Paus, Tomáš https://orcid.org/0000-0003-1495-9338
Poustka, Luise
Hohmann, Sarah
Millenet, Sabina
Fröhner, Juliane H. https://orcid.org/0000-0002-8493-6396
Robinson, Lauren
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Winterer, Jeanne
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Bhatt, Ravi R. https://orcid.org/0000-0003-2498-8888
Zhu, Alyssa
Conrod, Patricia
Jahanshad, Neda
Thompson, Paul M.
Mackey, Scott https://orcid.org/0000-0001-7817-7437
Garavan, Hugh https://orcid.org/0000-0002-8939-1014
,
,
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA047119, R01DA047119, R01DA047119, R01DA047119, R01DA047119, T32DA043593, R01DA047119)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | National Institutes of Health (R00AA024837, R01AA021449, R01DA023248, R21DA044749, R21DA045189, R01MH117601, R01AA013892, P50DA016656, UL1-DE021459, P30DA024859., R01MH117601, R01AG059874, R01MH121246, P41EB015922, R01MH116147, U54 EB020403, R01 MH116147, P41 EB015922, R01 MH111671)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91676084,31180002, 016.08.322, 31160003, 91676084, 31160003,31160004,016.08.322)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (ZIA-AA000123)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Netherlands Organisation for Scientific Research | Nationaal Regieorgaan Praktijkgericht Onderzoek SIA (453.08.01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 7 April 2022
Revised: 19 October 2022
Accepted: 24 October 2022
First Online: 15 November 2022
Competing interests
: TB served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire. He received conference support or speaker’s fee from Lilly, Medice, Novartis and Shire. He has been involved in clinical trials conducted by Shire and Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien and Oxford University Press. The present work is unrelated to the above grants and relationships. LP served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee from Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. RS has served on the scientific advisory board of Embera Neurotherapeutics. The other authors report no biomedical financial interests or potential conflicts of interest. NJ and PT are MPIs of a research grant from Biogen, Inc, for work unrelated to the contents of this manuscript. All other authors have no financial disclosures.
